Shoe Carnival, Inc. (Nasdaq: SCVL) (the “Company”), a leading retailer of footwear and accessories for the family, today reported results for the fourth quarter and fiscal year ended February 1, 2025 (“Fiscal 2024”) and provided annual guidance for its fiscal year ending on January 31, 2026 (“Fiscal 2025”).

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced the appointment of Diego Miralles, M.D. as a member of its board of directors, effective March 14, 2025.

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”) a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, today announced that it will effect a 1-for-25 reverse stock split (“reverse split”) of its common stock, par value $0.0001 per share (“Common Stock”), that will become effective at 12:01 a.m. Eastern Time on March 20, 2025. The Company’s Common Stock will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol “VRPX” and will begin trading on a split-adjusted basis when the Nasdaq opens on March ...

NEW YORK and TOKYO, March 19, 2025 /PRNewswire/ -- Mediagene Inc., a group company of TNL Mediagene (NASDAQ: TNMG), is pleased to announce the start of distribution for Labrador CMS in the Japanese market. Developed by LABRADOR CMS AS (Tordenskioldsgate 2, 0854 Oslo, Norway), Labrador CMS is an innovative content management system (CMS) designed specifically for professional news publishers.